胆汁酸代谢在消化系统肿瘤中的影响及作用机制研究进展
Research Progress on the Influence and Mechanism of Bile Acid Metabolism in Digestive System Tumors
DOI: 10.12677/jcpm.2025.42150, PDF,    科研立项经费支持
作者: 云 洁：内蒙古医科大学内蒙古临床学院，内蒙古 呼和浩特；边 超, 李智军*：内蒙古自治区人民医院放射治疗科，内蒙古 呼和浩特
关键词: 胆汁酸；消化系统肿瘤；机制；综述；Bile Acid； Digestive System Tumor； Mechanism； Review
摘要: 胆汁酸(BAs)对消化系统肿瘤的发生和发展具有重要影响。目前的研究已经证实，胆汁酸及其受体，如法尼醇X受体(FXR)和G蛋白偶联受体TGR5，在多种肿瘤的发生和发展中扮演着关键角色。此外，胆汁酸通过调节肿瘤微环境中的炎症反应和免疫反应，进一步影响肿瘤的进程。本文的目的是阐述胆汁酸与消化系统肿瘤发生发展的关系及其作用机制，主要通过氧化应激、DNA损伤、炎症反应、激活信号通路以及改变肿瘤微环境等途径，促进或抑制肿瘤的发展。我们总结了目前关于此领域研究的局限性，并为今后治疗肿瘤诊断标志物及治疗靶点提供新思路。
Abstract: Bile acids (BAs) have an important impact on the occurrence and development of digestive system tumors. Current studies have confirmed that bile acids and their receptors, such as farnesol X receptor (FXR) and G protein-coupled receptor TGR5, play a key role in the development and progression of different tumors. In addition, bile acids further influence tumor progression by modulating inflammatory and immune responses in the tumor microenvironment. The purpose of this paper is to elucidate the relationship between bile acids and the development and mechanism of different digestive system tumors, which can promote or inhibit the development of tumors through oxidative stress, DNA damage, inflammatory response, activation of signaling pathways, and change of tumor microenvironment. We summarize the limitations of current research in this area, and provide new ideas for the future treatment of tumor diagnostic markers and therapeutic targets.
文章引用：云洁, 边超, 李智军. 胆汁酸代谢在消化系统肿瘤中的影响及作用机制研究进展[J]. 临床个性化医学, 2025, 4(2): 85-91. https://doi.org/10.12677/jcpm.2025.42150

参考文献

[1] Fiorucci, S., Carino, A., Baldoni, M., Santucci, L., Costanzi, E., Graziosi, L., et al. (2020) Bile Acid Signaling in Inflammatory Bowel Diseases. Digestive Diseases and Sciences, 66, 674-693. [Google Scholar] [CrossRef] [PubMed]
[2] Wang, Y., Gao, X., Zhang, X., Xiao, Y., Huang, J., Yu, D., et al. (2019) Gut Microbiota Dysbiosis Is Associated with Altered Bile Acid Metabolism in Infantile Cholestasis. mSystems, 4, e00463-19. [Google Scholar] [CrossRef] [PubMed]
[3] Kühn, T., Stepien, M., López‐Nogueroles, M., et al. (2020) Prediagnostic Plasma Bile Acid Levels and Colon Cancer Risk: A Prospective Study. Journal of the National Cancer Institute, 112, 516-524.
[4] Yu, B., Peng, X.H., Wang, L.Y., et al. (2019) Abnormality of Intestinal Cholesterol Absorption in Apc (Min/+) Mice with Colon Cancer Cachexia. International Journal of Clinical and Experimental Pathology, 12, 759-767.
[5] Canovai, E., Farré, R., Accarie, A., Lauriola, M., De Hertogh, G., Vanuytsel, T., et al. (2023) INT-767—A Dual Farnesoid-X Receptor (FXR) and Takeda G Protein-Coupled Receptor-5 (TGR5) Agonist Improves Survival in Rats and Attenuates Intestinal Ischemia Reperfusion Injury. International Journal of Molecular Sciences, 24, Article 14881. [Google Scholar] [CrossRef] [PubMed]
[6] Jiao, N., Baker, S.S., Chapa-Rodriguez, A., Liu, W., Nugent, C.A., Tsompana, M., et al. (2017) Suppressed Hepatic Bile Acid Signalling Despite Elevated Production of Primary and Secondary Bile Acids in NAFLD. Gut, 67, 1881-1891. [Google Scholar] [CrossRef] [PubMed]
[7] Fleishman, J.S. and Kumar, S. (2024) Bile Acid Metabolism and Signaling in Health and Disease: Molecular Mechanisms and Therapeutic Targets. Signal Transduction and Targeted Therapy, 9, Article No. 97. [Google Scholar] [CrossRef] [PubMed]
[8] Ferrell, J.M., Boehme, S., Li, F. and Chiang, J.Y.L. (2016) Cholesterol 7α-Hydroxylase-Deficient Mice Are Protected from High-Fat/High-Cholesterol Diet-Induced Metabolic Disorders. Journal of Lipid Research, 57, 1144-1154. [Google Scholar] [CrossRef] [PubMed]
[9] Chiang, J.Y.L. (2017) Bile Acid Metabolism and Signaling in Liver Disease and Therapy. Liver Research, 1, 3-9. [Google Scholar] [CrossRef] [PubMed]
[10] Chiang, J.Y.L. and Ferrell, J.M. (2019) Bile Acids as Metabolic Regulators and Nutrient Sensors. Annual Review of Nutrition, 39, 175-200. [Google Scholar] [CrossRef] [PubMed]
[11] Sugiyama, Y., Yamamoto, K., Honda, T., Kato, A., Muto, H., Yokoyama, S., et al. (2023) Impact of Elobixibat on Liver Tumors, Microbiome, and Bile Acid Levels in a Mouse Model of Nonalcoholic Steatohepatitis. Hepatology International, 17, 1378-1392. [Google Scholar] [CrossRef] [PubMed]
[12] Nagahashi, M., Takabe, K., Liu, R., Peng, K., Wang, X., Wang, Y., et al. (2015) Conjugated Bile Acid-Activated S1P Receptor 2 Is a Key Regulator of Sphingosine Kinase 2 and Hepatic Gene Expression. Hepatology, 61, 1216-1226. [Google Scholar] [CrossRef] [PubMed]
[13] Zhao, H., Shang, L., Zhang, Y., Liang, Z., Wang, N., Zhang, Q., et al. (2024) IL-17A Inhibitors Alleviate Psoriasis with Concomitant Restoration of Intestinal/Skin Microbiota Homeostasis and Altered Microbiota Function. Frontiers in Immunology, 15, Article 1344963. [Google Scholar] [CrossRef] [PubMed]
[14] Nenkov, M., Shi, Y., Ma, Y., Gaßler, N. and Chen, Y. (2023) Targeting Farnesoid X Receptor in Tumor and the Tumor Microenvironment: Implication for Therapy. International Journal of Molecular Sciences, 25, Article 6. [Google Scholar] [CrossRef] [PubMed]
[15] Are, V.S., Gromski, M.A., Akisik, F., Vilar-Gomez, E., Lammert, C., Ghabril, M., et al. (2024) Primary Sclerosing Cholangitis Limited to Intrahepatic Bile Ducts Has Distinctly Better Prognosis. Digestive Diseases and Sciences, 69, 1421-1429. [Google Scholar] [CrossRef] [PubMed]
[16] Helal, M., Yan, C. and Gong, Z. (2021) Stimulation of Hepatocarcinogenesis by Activated Cholangiocytes via Il17a/f1 Pathway in Kras Transgenic Zebrafish Model. Scientific Reports, 11, Article No. 1372. [Google Scholar] [CrossRef] [PubMed]
[17] Sarkar, J., Aoki, H., Wu, R., Aoki, M., Hylemon, P., Zhou, H., et al. (2022) Conjugated Bile Acids Accelerate Progression of Pancreatic Cancer Metastasis via S1PR2 Signaling in Cholestasis. Annals of Surgical Oncology, 30, 1630-1641. [Google Scholar] [CrossRef] [PubMed]
[18] Feng, H. and Chen, Y. (2016) Role of Bile Acids in Carcinogenesis of Pancreatic Cancer: An Old Topic with New Perspective. World Journal of Gastroenterology, 22, 7463-7477. [Google Scholar] [CrossRef] [PubMed]
[19] Phelan, J.P., Reen, F.J., Caparros-Martin, J.A., O’Connor, R. and O’Gara, F. (2017) Rethinking the Bile Acid/Gut Microbiome Axis in Cancer. Oncotarget, 8, 115736-115747. [Google Scholar] [CrossRef] [PubMed]
[20] Thomas, R.M. and Jobin, C. (2019) Microbiota in Pancreatic Health and Disease: The Next Frontier in Microbiome Research. Nature Reviews Gastroenterology & Hepatology, 17, 53-64. [Google Scholar] [CrossRef] [PubMed]
[21] Winston, J.A. and Theriot, C.M. (2019) Diversification of Host Bile Acids by Members of the Gut Microbiota. Gut Microbes, 11, 158-171. [Google Scholar] [CrossRef] [PubMed]
[22] Chai, J., Norng, M., Modak, C., Reavis, K.M., Mouazzen, W. and Pham, J. (2010) CCN1 Induces a Reversible Epithelial-Mesenchymal Transition in Gastric Epithelial Cells. Laboratory Investigation, 90, 1140-1151. [Google Scholar] [CrossRef] [PubMed]
[23] Dang, T., Modak, C., Meng, X., Wu, J., Narvaez, R. and Chai, J. (2017) CCN1 Sensitizes Esophageal Cancer Cells to Trail-Mediated Apoptosis. Experimental Cell Research, 361, 163-169. [Google Scholar] [CrossRef] [PubMed]
[24] Heck, A.L., Mishra, S., Prenzel, T., Feulner, L., Achhammer, E., Särchen, V., et al. (2021) Selective HSP90β Inhibition Results in TNF and TRAIL Mediated HIF1α Degradation. Immunobiology, 226, Article ID: 152070. [Google Scholar] [CrossRef] [PubMed]
[25] Mukaisho, K., Kanai, S., Kushima, R., Nakayama, T., Hattori, T. and Sugihara, H. (2019) Barretts’s Carcinogenesis. Pathology International, 69, 319-330. [Google Scholar] [CrossRef] [PubMed]
[26] Molendijk, J., Kolka, C.M., Cairns, H., Brosda, S., Mohamed, A., Shah, A.K., et al. (2022) Elevation of Fatty Acid Desaturase 2 in Esophageal Adenocarcinoma Increases Polyunsaturated Lipids and May Exacerbate Bile Acid‐induced DNA Damage. Clinical and Translational Medicine, 12, e810. [Google Scholar] [CrossRef] [PubMed]
[27] Meng, X., Chang, Z., Che, N., Wu, J., Dang, T. and Chai, J. (2020) Acid/Bile Exposure Triggers Trail-Mediated Apoptosis in Esophageal Cancer Cells by Suppressing the Decoy Receptors and C-FLIPR. The International Journal of Biochemistry & Cell Biology, 122, Article ID: 105736. [Google Scholar] [CrossRef] [PubMed]
[28] Chen, H., Hu, Y., Lu, N. and Zhu, Y. (2020) Caudal Type Homeoboxes as a Driving Force in Helicobacter pylori Infection-Induced Gastric Intestinal Metaplasia. Gut Microbes, 12, Article ID: 1809331. [Google Scholar] [CrossRef] [PubMed]
[29] Bhat, A.A., Lu, H., Soutto, M., Capobianco, A., Rai, P., Zaika, A., et al. (2018) Exposure of Barrett’s and Esophageal Adenocarcinoma Cells to Bile Acids Activates EGFR-STAT3 Signaling Axis via Induction of Ape1. Oncogene, 37, 6011-6024. [Google Scholar] [CrossRef] [PubMed]
[30] Lozupone, C.A., Stombaugh, J.I., Gordon, J.I., Jansson, J.K. and Knight, R. (2012) Diversity, Stability and Resilience of the Human Gut Microbiota. Nature, 489, 220-230. [Google Scholar] [CrossRef] [PubMed]
[31] Jin, D., Huang, K., Xu, M., Hua, H., Ye, F., Yan, J., et al. (2022) Deoxycholic Acid Induces Gastric Intestinal Metaplasia by Activating STAT3 Signaling and Disturbing Gastric Bile Acids Metabolism and Microbiota. Gut Microbes, 14, Article: 2120744. [Google Scholar] [CrossRef] [PubMed]
[32] Bernstein, C., Holubec, H., Bhattacharyya, A.K., Nguyen, H., Payne, C.M., Zaitlin, B., et al. (2011) Carcinogenicity of Deoxycholate, a Secondary Bile Acid. Archives of Toxicology, 85, 863-871. [Google Scholar] [CrossRef] [PubMed]
[33] Huang, X., Zhao, W. and Huang, W. (2014) FXR and Liver Carcinogenesis. Acta Pharmacologica Sinica, 36, 37-43. [Google Scholar] [CrossRef] [PubMed]
[34] Zhuang, Y., Ortega-Ribera, M., Thevkar Nagesh, P., Joshi, R., Huang, H., Wang, Y., et al. (2023) Bile Acid-Induced IRF3 Phosphorylation Mediates Cell Death, Inflammatory Responses, and Fibrosis in Cholestasis-Induced Liver and Kidney Injury via Regulation of ZBP1. Hepatology, 79, 752-767. [Google Scholar] [CrossRef] [PubMed]
[35] Nagahashi, M., Yuza, K., Hirose, Y., Nakajima, M., Ramanathan, R., Hait, N.C., et al. (2016) The Roles of Bile Acids and Sphingosine-1-Phosphate Signaling in the Hepatobiliary Diseases. Journal of Lipid Research, 57, 1636-1643. [Google Scholar] [CrossRef] [PubMed]
[36] Reich, M., Deutschmann, K., Sommerfeld, A., Klindt, C., Kluge, S., Kubitz, R., et al. (2015) TGR5 Is Essential for Bile Acid-Dependent Cholangiocyte Proliferation in Vivo and in Vitro. Gut, 65, 487-501. [Google Scholar] [CrossRef] [PubMed]
[37] Terabe, M. and Berzofsky, J.A. (2016) NKT Cells in Tumor Immunity. Encyclopedia of Immunobiology, 4, 460-469. [Google Scholar] [CrossRef] 
[38] Ma, C., Han, M., Heinrich, B., Fu, Q., Zhang, Q., Sandhu, M., et al. (2018) Gut Microbiome-Mediated Bile Acid Metabolism Regulates Liver Cancer via NKT Cells. Science, 360, eaan5931. [Google Scholar] [CrossRef] [PubMed]
[39] Olszak, T., An, D., Zeissig, S., Vera, M.P., Richter, J., Franke, A., et al. (2012) Microbial Exposure during Early Life Has Persistent Effects on Natural Killer T Cell Function. Science, 336, 489-493. [Google Scholar] [CrossRef] [PubMed]
[40] Gándola, Y.B., Fontana, C., Bojorge, M.A., Luschnat, T.T., Moretton, M.A., et al. (2020) Concentration-Dependent Effects of Sodium Cholate and Deoxycholate Bile Salts on Breast Cancer Cells Proliferation and Survival. Molecular Biology Reports, 47, 3521-3539. [Google Scholar] [CrossRef] [PubMed]